GANCICLOVIR TREATMENT OF SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS INFECTION: RESULTS OF A PHASE II STUDY. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES COLLABORATIVE ANTIVIRAL STUDY GROUP

WHITLEY, R.J., CLOUD, G., GRUBER, W., STORCH, G.A., DEMMLER, G.J., & JACOBS, R.F.. (1997). GANCICLOVIR TREATMENT OF SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS INFECTION: RESULTS OF A PHASE II STUDY. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES COLLABORATIVE ANTIVIRAL STUDY GROUP. JOURNAL OF INFECTIOUS DISEASES, 175(5), 1080-1086. SID. https://sid.ir/paper/559756/en

WHITLEY R.J., CLOUD G., GRUBER W., STORCH G.A., DEMMLER G.J., JACOBS R.F.. GANCICLOVIR TREATMENT OF SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS INFECTION: RESULTS OF A PHASE II STUDY. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES COLLABORATIVE ANTIVIRAL STUDY GROUP. JOURNAL OF INFECTIOUS DISEASES[Internet]. 1997;175(5):1080-1086. Available from: https://sid.ir/paper/559756/en

R.J. WHITLEY, G. CLOUD, W. GRUBER, G.A. STORCH, G.J. DEMMLER, and R.F. JACOBS, “GANCICLOVIR TREATMENT OF SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS INFECTION: RESULTS OF A PHASE II STUDY. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES COLLABORATIVE ANTIVIRAL STUDY GROUP,” JOURNAL OF INFECTIOUS DISEASES, vol. 175, no. 5, pp. 1080–1086, 1997, [Online]. Available: https://sid.ir/paper/559756/en